Prenatal DNA test may uncover Mom's cancer risk

NCT ID NCT04049604

Recruiting now Knowledge-focused Sponsor: National Human Genome Research Institute (NHGRI) Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at pregnant women whose routine blood tests for the baby's DNA came back unusual or unclear. Researchers want to find out if these results can signal cancer in the mother. Participants will have imaging, lab tests, and surveys, and may be followed for up to 5 years. The goal is to better understand the link between these test results and cancer, not to provide a direct treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MATERNAL NEOPLASIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

malignancy diagnosed during pregnancy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MATERNAL NEOPLASIA

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

National Institutes of Health Clinical Center
RECRUITING

Bethesda, Maryland, 20892, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••